Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?
Authors not listed
Hospices Civils de Lyon · 2009
Abstract
The potential clinical implications of this study are to optimise the selection of a population at risk for developing a diabetic cardiomyopathy among diabetic patients in order to develop early therapeutic strategies to prevent the left ventricular remodelling.
Therefore, the originality of this project is to hypothesize that :
* Diabetes mellitus is often associated with a premature aging syndrome
* Cellular senescence(definition) may potentiate the mechanisms that are involved in decreasing myocardial contractility in DM and,
* DM associated to premature aging may increase the risk of developing a cardiomyopathy Thus, the modulation of telomerase activity and the control of telomere(definition) length, together with the attenuation of the formation of reactive oxygen species, might represent important new targets in order to develop therapeutic tools in prevention of diabetic cardiomyopathy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2009). Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?. <em>Hospices Civils de Lyon</em>. https://clinicaltrials.gov/study/NCT01536808
Vancouver
Anonymous. Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?. Hospices Civils de Lyon. 2009.
BibTeX
@misc{anon2009Premat,
title = {Premature Aging and Type 2 Diabetes Mellitus: an Increased Risk of Cardiomyopathy?},
author = {Anonymous},
journal = {Hospices Civils de Lyon},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
JAMA ophthalmology 2026
Citation only
Reported Metformin Use and Age-Related Macular Degeneration in Patients With Diabetes.
ACS Biomarker 2016
Open access · US-GOV
Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure. A Proof of Concept Clinical Trial Within the EU FP 7 (European Union FP7) "HOMAGE" Programme " Heart OMics in AGing "
The Journal of Clinical Endocrinology & Metabolism 2014
Citation only
Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome
Aging and Disease 2015
Open access · CC-BY
Metabolic Syndrome, Aging and Involvement of Oxidative Stress
Frontiers in Molecular Neuroscience 2022
Open access · CC-BY
Early Adversity and Accelerated Brain Aging: A Mini-Review
Evolution 1957
Citation only